Keywords: NPS Pharmaceuticals, Gattex, Short bowel syndrome, USA, FDA advisory panel

Unanimous FDA advisory panel backing for NPS Pharma's Gattex

Article | 17 October 2012

Print This

The US Food and Drug Administration’s Gastrointestinal Drugs Advisory Committee yesterday voted unanimously to recommend approval of NPS ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in